Research Projects
Vaccines exploit the ability of the immune system to provide heightened, tailored responses to pathogens if the host has been infected prior – this...
Supervisor: Professor Kim Good-Jacobson
We are interested in delineating the molecular pathways that control immune cell function during infection and inflammation. Our group is focused on...
Supervisor: Professor Colby Zaph
The innate immune system is the body’s first line of defence against infection, and is necessary for our survival. Our cells have evolved specialized...
Supervisor: Dr. Natalia G. Sampaio
This project aims to better define rates of reactivation from the point of initial exposure/infection to the later development of active TB. The...
Supervisor: A/Prof James Trauer
A sudden worsening of respiratory symptoms in Chronic obstructive Pulmonary Disease (COPD) is called a flare up. These flare ups are caused by...
Supervisor: Dr Arwel Jones
Exploring antimicrobial resistance plasmid diversity at a single hospital network in a 7-year period
Plasmid transmission between bacteria of the same or different species is an important driver of genetic diversity, bacterial adaptation and...
Supervisor: Dr Margaret Lam
Polysaccharide capsule is a critical virulence factor in many bacteria, including the priority drug-resistant pathogen Acinetobacter baumannii. The...
Supervisor: Dr Francesca Short
The COVID19 pandemic has highlighted the vulnerability of older individuals to suffer more severe disease outcomes from infectious respiratory...
Supervisor: Dr Anna Hearps
Exosomes are small vesicles (50-150 nm in size) secreted by most cell types and are involved in cell - cell communication and regulation of immune...
Supervisor: Professor Brian Cooke
The Lieschke group studies the haemopoietic system and leukocytes. The haemopoietic system is a collection of organs
and tissues (bone marrow,...
Supervisor: Professor Graham Lieschke AM
Klebsiella pneumoniae is a major cause of antibiotic resistant hospital-associated infections that can be extremely difficult to treat. The World...
Supervisor: Dr Kelly Wyres
The treatment of bacterial infections in humans and animals has largely relied on the use of antibiotics for over 70 years. One consequence of the...
Supervisor: Professor Dena Lyras
Antibody development in response to infection and vaccination in humans is poorly understood, in part due to the difficult in accessing secondary...
Supervisor: A/Prof Michelle Boyle
The importance of hospital admissions data to inform health policy has been evident over the past few years, with the pressure that the COVID-19...
Supervisor: Dr Daniel Griffiths
The eukaryotic genome consists of two classes of genes preceded by distinctly different promoter sequences. Housekeeping genes (90%) code for...
Supervisor: Dr Hans Elmlund
Gastric cancer is a leading cause of cancer-related death, claiming more than 1 million lives annually. A major predisposing factor to developing...
Supervisor: Dr Dustin Flanagan
Plasma cells (PC) are the only cell type secreting antibodies, which are important for protective immunity to fight against pathogens. However,...
Supervisor: Dr Zhoujie (Zoe) Ding
Group A Streptococcus hijacks host plasminogen to facilitate colonization and dissemination. This infection can lead to life-threatening infections...
Supervisor: Dr Ruby Law
To be able to stave off infections and cancers throughout life, our immune systems first need to recognise and tolerate the ~200 different cell types...
Supervisor: Dr Stephen Daley
The adaptive arm of immune system uses lymphocytes to generate antibody and memory responses to challenges throughout life. Three lineages of...
Supervisor: Dr Martin Davey